Multiple biologic markers in the monitoring of treatment for patients with small cell carcinoma of the lung: the use of serial levels of plasma CEA and serum carbohydrates.

Abstract:

:The monitoring utility of serial patterns of a single marker (carcinoembryonic antigen) level and multiple marker (three carbohydrates-fucose, mannose and galactose) levels in patients with small cell carcinoma of the lung was investigated using a quantitative approach. A serial multiple regression (SMR) model was formulated to assess the disease response following the first to the tenth course of therapy and resulted in the multiple correlations ranging from 0.183 (NS)-0.706 (P less than 0.005) for CEA, and 0.502 (P less than 0.250)-0.760 (P less than 0.025) for three carbohydrates, respectively. The appraisal of these markers utilizing the SMR model points out that: (1) the serial levels of CEA greater than 5.0 ng/ml are significantly correlated with the disease course whereas the serial levels less than 5.0 ng/ml reflect the trend of variation in the disease course, but with less accuracy; and (2) the levels of three carbohydrates, any one elevated before and during therapy, are significantly correlated with the disease course.

journal_name

Cancer

journal_title

Cancer

authors

Woo KB,Waalkes P,Abeloff MD,Ettinger DS,McNitt KL,Gehrke CW

doi

10.1002/1097-0142(19811001)48:7<1633::aid-cncr2820

subject

Has Abstract

pub_date

1981-10-01 00:00:00

pages

1633-42

issue

7

eissn

0008-543X

issn

1097-0142

journal_volume

48

pub_type

杂志文章

相关文献

CANCER文献大全
  • Perception, paradox, paradigm: Alice in the wonderland of lung cancer prevention and early detection.

    abstract:BACKGROUND:In less than a century, lung cancer has progressed from a medical curiosity to the most deadly of all malignant diseases on our planet. Because cigarette smoking is responsible for the existing global lung cancer epidemic, policy initiatives have focused almost exclusively on primary prevention. There is no ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(20001201)89:11+<2422::aid-cncr16

    authors: Strauss GM,Dominioni L

    更新日期:2000-12-01 00:00:00

  • Binding of soybean agglutinin lectin to prostatic hyperplasia and adenocarcinoma.

    abstract::The binding of soybean agglutinin (SBA) lectin to routinely processed surgical pathology material from cases of prostatic hyperplasia, atypical hyperplasia, and adenocarcinoma was studied using an immunoperoxidase technique. Positive staining was obtained in eight of eight cases of nodular hyperplasia, eight of eight ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890415)63:8<1583::aid-cncr2820

    authors: Loy TS,Kyle J,Bickel JT

    更新日期:1989-04-15 00:00:00

  • Squamous cell carcinoma of the buccal mucosa associated with chronic oral polyvinyl chloride exposure: report of a case.

    abstract::The following case report describes a 22-year-old healthy man, non-smoker, non-drinker, who developed a squamous cell carcinoma of the buccal mucosa. The appearance of this unusual tumor in an unexpected clinical setting was unexplained until it was discovered that the patient had a lifetime habit of chewing plastic m...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197704)39:4<1686::aid-cncr282039

    authors: Casterline CL,Casterline PF,Jaques DA

    更新日期:1977-04-01 00:00:00

  • Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.

    abstract:BACKGROUND:Early-phase trials in patients with recurrent neuroblastoma historically used an objective "response" of measureable disease (Response Evaluation Criteria In Solid Tumors [RECIST], without bone/bone marrow assessment) to select agents for further study. Historical cohorts may be small and potentially biased;...

    journal_title:Cancer

    pub_type: 杂志文章,meta分析,评审

    doi:10.1002/cncr.30934

    authors: London WB,Bagatell R,Weigel BJ,Fox E,Guo D,Van Ryn C,Naranjo A,Park JR

    更新日期:2017-12-15 00:00:00

  • Radiotherapy for malignant fistula to other tract.

    abstract::Radiotherapy was applied to 14 esophageal carcinomas with respiratory tract fistulas using various treatment regimens. Closure of the fistulas was observed in four cases after irradiation at a daily dose of 1.5 Gy. The period of closure was transient in two cases but long-term in the other two. One long-term closure c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890901)64:5<1026::aid-cncr2820

    authors: Yamada S,Takai Y,Ogawa Y,Kakuto Y,Sakamoto K

    更新日期:1989-09-01 00:00:00

  • Bowenoid dysplasia of the vulva.

    abstract::The histologic findings of five patients with clinically typical Bowenoid dysplasia (BD) allowed the authors to classify the vulvar and perineal biopsies of 18 patients under 40 years as BD and the vulvar biopsies of six patients under 40 years as squamous cell carcinoma in situ (CIS). The two best criteria for BD are...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19821215)50:12<2910::aid-cncr282

    authors: Ulbright TM,Stehman FB,Roth LM,Ehrlich CE,Ransburg RC

    更新日期:1982-12-15 00:00:00

  • Preoperative experience for public hospital patients with gynecologic cancer: Do structural barriers widen the gap?

    abstract:BACKGROUND:Widespread disparities in care have been documented in women with gynecologic cancer in the United States. This study was designed to determine whether structural barriers to optimal care were present during the preoperative period for patients with gynecologic cancer. METHODS:A retrospective review was con...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29859

    authors: Frey MK,Moss HA,Musa F,Rolnitzky L,David-West G,Chern JY,Boyd LR,Curtin JP

    更新日期:2016-03-15 00:00:00

  • Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.

    abstract:BACKGROUND:The purpose was to compare the differential expression of Survivin in normal bladder tissue, bladder transitional cell carcinoma (TCC) of different stages, and to determine whether expression of Survivin is associated with TCC clinical outcomes. METHODS:Immunohistochemical staining for Survivin was carried ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22521

    authors: Shariat SF,Ashfaq R,Karakiewicz PI,Saeedi O,Sagalowsky AI,Lotan Y

    更新日期:2007-03-15 00:00:00

  • Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma.

    abstract:BACKGROUND:To evaluate the hearing preservation rate and to determine its prognostic factors after gamma knife (GK) stereotactic radiosurgery (SRS) in patients with vestibular schwannoma, the authors used a prospective study design to analyze these patients. METHODS:Between December 1997 and January 2002, 25 patients ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21190

    authors: Paek SH,Chung HT,Jeong SS,Park CK,Kim CY,Kim JE,Kim DG,Jung HW

    更新日期:2005-08-01 00:00:00

  • High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas.

    abstract:BACKGROUND:To identify the factors that contribute to poorer colon carcinoma survival rates for African Americans compared with Caucasians, the authors evaluated survival differences based on the histologic grade (differentiation) of the tumor. METHODS:All 169 African Americans and 229 randomly selected non-Hispanic C...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21021

    authors: Alexander D,Jhala N,Chatla C,Steinhauer J,Funkhouser E,Coffey CS,Grizzle WE,Manne U

    更新日期:2005-05-15 00:00:00

  • Cancer and total mortality among active Mormons.

    abstract::Based on Church records for 15,500 California Mormons during 1968 to 1975 and for 55,000 Utah Mormons during 1970 and 1975, the ratio of age-adjusted death rates for religiously active Mormon males compared with U.S. white males is 38% for ages 35 to 64 years and 50% for ages 35 years and above. The remaining life exp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197810)42:4<1943::aid-cncr282042

    authors: Enstrom JE

    更新日期:1978-10-01 00:00:00

  • A Southwest Oncology Group phase II Trial of recombinant tumor necrosis factor in metastatic breast cancer.

    abstract::New approaches are needed in the treatment of advanced breast cancer. In vitro studies have shown that recombinant tumor necrosis factor (TNF) is a growth inhibitor for the MCF-7, ZR-75-1, and BT-20 human breast cancer cell lines. Based on these considerations, the Southwest Oncology Group performed a Phase II trial o...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19911015)68:8<1694::aid-cncr2820

    authors: Budd GT,Green S,Baker LH,Hersh EP,Weick JK,Osborne CK

    更新日期:1991-10-15 00:00:00

  • Bone mineral density in young adult survivors of acute lymphoblastic leukemia.

    abstract:BACKGROUND:The purpose of the current study was to determine the prevalence of low bone mineral density (BMD) (ie, osteopenia) and identify factors associated with low BMD in young adult survivors of childhood acute lymphoblastic leukemia (ALL). METHODS:Dual energy x-ray absorptiometry was used to evaluate BMD in 74 r...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23912

    authors: Thomas IH,Donohue JE,Ness KK,Dengel DR,Baker KS,Gurney JG

    更新日期:2008-12-01 00:00:00

  • Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer.

    abstract:BACKGROUND:This study assessed the impact of surgical, histopathologic and patient-related factors on the risks of local and distant recurrence and overall survival for patients with stages I through IIIA nonsmall cell lung carcinoma (NSCLC) undergoing definitive resection with or without adjuvant chemotherapy. METHOD...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24133

    authors: Varlotto JM,Recht A,Flickinger JC,Medford-Davis LN,Dyer AM,Decamp MM

    更新日期:2009-03-01 00:00:00

  • Phase 1/2 study of DFP-10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemia.

    abstract:BACKGROUND:DFP-10917, a deoxycytidine nucleoside analogue, has a unique mechanism of action resulting in leukemic cell death when administered for prolonged periods at low doses. The current phase 1/2 study investigated the safety, maximum tolerated dose, and evidence of antileukemic activity for DFP-10917 administered...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31923

    authors: Kantarjian HM,Jabbour EJ,Garcia-Manero G,Kadia TM,DiNardo CD,Daver NG,Borthakur G,Jain N,Waukau JB,Kwari MI,Ravandi F,Anderson BD,Iizuka K,Jin C,Zhang C,Plunkett WK

    更新日期:2019-05-15 00:00:00

  • Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status.

    abstract:BACKGROUND:Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) tests are commonly used to assess human epidermal growth factor 2 (HER2) status of tumors in patients with breast cancer. This analysis evaluates the likely cost-effectiveness of expanded retesting to assess HER2 tumor status in women w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28196

    authors: Garrison LP Jr,Lalla D,Brammer M,Babigumira JB,Wang B,Perez EA

    更新日期:2013-09-01 00:00:00

  • Effects of hepatic arterial yttrium 90 glass microspheres in dogs.

    abstract::A 22-micron glass microsphere called TheraSphere (Theragenics Corp., Atlanta, GA) has been developed in which yttrium 89 oxide is incorporated into the glass matrix and is activated by neutron bombardment to form the beta-emitting isotope yttrium 90 (Y 90) before using the spheres as radiotherapeutic vehicles. The inj...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880401)61:7<1336::aid-cncr2820

    authors: Wollner I,Knutsen C,Smith P,Prieskorn D,Chrisp C,Andrews J,Juni J,Warber S,Klevering J,Crudup J

    更新日期:1988-04-01 00:00:00

  • Esthesioneuroblastoma masquerading as extramedullary plasmacytoma.

    abstract::Nine years after biopsy and radiation therapy for an extramedullary plasmacytoma of the nasal cavity, a 64-year-old man developed locally recurrent tumor. Repeat biopsy revealed tumor identical in hematoxylin and eosin stain (H & E) appearance to that found originally, leading to the diagnosis of recurrent extramedull...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870701)60:1<88::aid-cncr282060

    authors: Abrams RA,Wilson JF,Komorowski RA,Collins D,Toohill RJ

    更新日期:1987-07-01 00:00:00

  • Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells.

    abstract:BACKGROUND:The authors analyzed the secretion of extracellular matrix-degrading proteinases, including urinary-type plasminogen activator (u-PA), matrix metalloproteinase-2 (MMP-2, gelatinase A), and MMP-9 (gelatinase B), by short term primary cultures of epithelial ovarian carcinoma cells derived from primary ovarian ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19971015)80:8<1457::aid-cn

    authors: Fishman DA,Bafetti LM,Banionis S,Kearns AS,Chilukuri K,Stack MS

    更新日期:1997-10-15 00:00:00

  • Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myeloma.

    abstract:BACKGROUND:The bone destruction in myeloma patients is largely responsible for the clinical features of the disease. However, only recently has attention focused on identifying and developing drugs targeted specifically at the osteolysis. Receptor activator of NF-kappaB ligand (RANKL), macrophage inflammatory protein (...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11133

    authors: Oyajobi BO,Mundy GR

    更新日期:2003-02-01 00:00:00

  • A reliable method for evaluating drug compliance in children with cancer.

    abstract::Poor drug compliance may cause a decreased survival of children with malignancies. Children who fail to take their medications are not receiving optimum amounts of chemotherapy and suboptimal therapy causes a shortened survival in children with cancer. This is a study of prednisone compliance in 52 children with cance...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197901)43:1<169::aid-cncr2820430

    authors: Smith SD,Rosen D,Trueworthy RC,Lowman JT

    更新日期:1979-01-01 00:00:00

  • Receipt of cancer screening procedures among Hispanic and non-Hispanic health maintenance organization members.

    abstract:BACKGROUND:Hispanic Americans have been shown to receive fewer cancer screening procedures than nonminority populations. Although lack of insurance or a regular source of care appear to be important determinants, cultural factors also have been suggested. This study examines whether Hispanic patients receive cancer scr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010101)91:1+<257::aid-cncr15>3

    authors: Jacobs EA,Lauderdale DS

    更新日期:2001-01-01 00:00:00

  • Tumor vaccine for ovarian carcinoma targeting sperm protein 17.

    abstract:BACKGROUND:The authors previously identified sperm protein 17 (Sp17) as being expressed in patients with multiple myeloma. The restricted expression of Sp17 in normal tissue makes it an ideal target for tumor vaccine. In the current study, the authors extended their research to include ovarian carcinoma. METHODS:A pai...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10506

    authors: Chiriva-Internati M,Wang Z,Salati E,Timmins P,Lim SH

    更新日期:2002-05-01 00:00:00

  • Immunohistochemical identification of tissue factor in solid tumors.

    abstract::Patients with cancer experience a much higher than expected incidence of thromboembolic disorders, commonly referred as Trousseau syndrome. Although this association has been well documented, the etiology of the hypercoagulable state is not known. The expression on tumor cells of tissue factor (TF), a membrane-bound l...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920901)70:5<1194::aid-cncr2820

    authors: Callander NS,Varki N,Rao LV

    更新日期:1992-09-01 00:00:00

  • Oncology clinic attendance at an inner city hospital.

    abstract::Compliance in oncology clinic attendance was prospectively evaluated over a 12-month period at Harlem Hospital Center, an inner city municipal facility serving a predominantly black population. One hundred patients were followed (97 blacks, 2 Hispanics, 1 white) with an average age of 60 years. There were 41 men and 5...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860801)58:3<793::aid-cncr28205

    authors: Garrett TJ,Ashford A,Savage DG

    更新日期:1986-08-01 00:00:00

  • Symptom profiles in children with advanced cancer: Patient, family caregiver, and oncologist ratings.

    abstract:BACKGROUND:Systematic symptom assessment is not routinely performed in pediatric oncology. The objectives of the current study were to characterize the symptoms of pediatric oncology outpatients and evaluate agreement between patient and proxy reports and the association between children's ratings and oncologists' trea...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29597

    authors: Zhukovsky DS,Rozmus CL,Robert RS,Bruera E,Wells RJ,Chisholm GB,Allo JA,Cohen MZ

    更新日期:2015-11-15 00:00:00

  • Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure.

    abstract:BACKGROUND:Despite improvements in survival rates, cancer treatments have significant side effects that affect the quality of life of children and their families. When an ill child cannot self-report symptoms (eg, he or she is too ill), caregiver (parent) reporting becomes critical. This study evaluates the validity an...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33389

    authors: Reeve BB,McFatrich M,Lin L,Lucas NR,Mack JW,Jacobs SS,Withycombe JS,Baker JN,Freyer DR,Hinds PS

    更新日期:2020-12-17 00:00:00

  • Does multisomy of chromosome 1q confer a proliferative advantage in B-cell acute lymphoblastic leukemia?

    abstract::Two patients fulfilled the clinical and hematologic criteria for B-cell acute lymphoblastic leukemia: the malignant cells had L3 morphology, bore B-cell markers, and carried the specific t(8;14) translocation. The leukemic cells of one patient were tetrasomic for 1q, and those of the other patient showed several separ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840701)54:1<48::aid-cncr282054

    authors: Morris CM,Fitzgerald PH,Neville MA,Wyld PJ,Beard ME

    更新日期:1984-07-01 00:00:00

  • Malignant "Triton" tumors. Natural history and immunohistochemistry of nine new cases with literature review.

    abstract::Malignant schwannomas with rhabdomyoblastic differentiation have been termed malignant "Triton" tumors (MTT). To define the natural history of MTT, we have analyzed our experience (9 cases, the largest series reported) in combination with the 27 previously described in the literature (total 36 cases). This study was i...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850601)55:11<2543::aid-cncr282

    authors: Brooks JS,Freeman M,Enterline HT

    更新日期:1985-06-01 00:00:00

  • Concurrent radiation therapy, 5-fluorouracil, and cisplatin for stage II, III, and IV, node-negative, squamous cell head and neck cancer. Results and surgical implications.

    abstract:METHODS:Between 1983 and 1989, 42 patients with Stage II, III, and IV, node-negative, squamous cell head and neck cancer were treated with concurrent 5-fluorouracil, cisplatin, and radiation therapy. Two courses of chemotherapy with 30 Gy of concurrent radiation therapy were to be followed in all patients by definitive...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19921201)70:11<2685::aid-cncr282

    authors: Adelstein DJ,Sharan VM,Damm C,Earle AS,Shah AC,Haria CD,Trey JE,Carter SG,Hines JD

    更新日期:1992-12-01 00:00:00